2022
DOI: 10.1039/d2sc02554j
|View full text |Cite
|
Sign up to set email alerts
|

Biomimetically constructing a hypoxia-activated programmable phototheranostics at the molecular level

Abstract: A programmable strategy at the molecular level to modulate the ratio of a catalyst and photosensitizer to maximize the collaborative efficiency of anti-angiogenesis and PDT.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…In comparison to control complex 57 , 56 produces dioxygen 6.8 times faster. The reaction occurs in PBS buffer at a pH of 7.4 In a following work, 56 has been combined with a photosensitizer to construct a programmable phototheranostics [81] …”
Section: Endohedral Group Acts As a Ligandmentioning
confidence: 99%
“…In comparison to control complex 57 , 56 produces dioxygen 6.8 times faster. The reaction occurs in PBS buffer at a pH of 7.4 In a following work, 56 has been combined with a photosensitizer to construct a programmable phototheranostics [81] …”
Section: Endohedral Group Acts As a Ligandmentioning
confidence: 99%
“…Introducing a metal center into an organic ligand framework via metal coordination offers an attractive means of designing PSs by allowing access to metal-centered excited states and reactivity. Recent work from our laboratory ,, revealed that appropriately designed Ni­(II) complexes can function as photothermal agents whose excited state energies can be dissipated via thermally accessible radiationless relaxation mechanisms, arising from their small d–d ligand-field splittings . Separate studies of Ni­(II) complexes as metalloenzyme catalysts led us to consider the possibility of using them to catalyze Fenton-like reactions intracellularly, thus reprograming the TME to be less immunosuppressive.…”
Section: Introductionmentioning
confidence: 99%
“…In recent decades, photodynamic therapy (PDT) has received considerable attention for cancer treatment due to its ability to enhance cancer treatment through the generation of reactive oxygen species (ROS) upon light irradiation [1][2][3][4][5]. The photosensitizers (PSs) that are closely related to the effectiveness of PDT are especially critical [6][7][8][9]. When exposed to white light or laser, PSs can undergo type-II photochemical reactions to generate singlet oxygens ( 1 O 2 , energy transfer) or type-I reactions to generate toxic radicals (O 2…”
Section: Introductionmentioning
confidence: 99%